Amarin's Omega-3 Fair Trade Complaint Reaches Regulatory Dead End
This article was originally published in The Rose Sheet
Executive Summary
International Trade Commission won't investigate Amarin's complaint that some dietary supplements containing omega-3 formulations similar to icosapent ethyl in its Vascepa are actually drugs and should be blocked from import into US, likely discouraging others from this novel approach.